Companies › PDSB
PDS BIOTECHNOLOGY CORP (PDSB)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001472091 · EDGAR filings · Updated 2026-07-21
PDS BIOTECHNOLOGY CORP (PDSB) has reported institutional ownership of 9.0%, with 40 institutional managers holding positions valued at $3.05M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-21 — EFFECT filed
- 2026-07-21 — Prospectus supplement (424B4) filed
- 2026-07-10 — Shelf registration (S-3) filed
- 2026-06-26 — ARS filed
- 2026-06-26 — DEFA14A filed
- 2026-06-26 — Proxy statement (DEF 14A) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, PDS BIOTECHNOLOGY CORP has 40 institutional holders and institutional ownership of 9.0%.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
Rockwell Medical Inc (RMTI) · ENLIVEX LTD COM (ENLV) · GREENLAND MINES LTD (GRML) · IRIDEX CORP (IRIX) · Telomir Pharmaceuticals Inc (TELO) · Celularity Inc (CELU)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-21.